WHO ICTRP trial
Safety and effectiveness assessment of Fiorage L. gel for nasolabial folds…
IRCT20150101020514N12 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT20150101020514N12 |
|---|---|
| Public title | Safety and effectiveness assessment of Fiorage L. gel for nasolabial folds correction |
| Scientific title | Safety and effectiveness assessment of Fiorage L. gel produced by Orchid Pharmed company for nasolabial folds correction |
| Primary sponsor | Zist orchid pharmed Company |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Phase | 2 |
| Countries | Iran (Islamic Republic of) |
| Conditions | Skin aging. |
| Interventions | Intervention group: one injection with 1-2 cc Fiorage L injectable gel in each nasolabial fold. The product is 1cc prefilled sterilized syringe containing: Hyaluronic Acid gel, 24 mg Lidocaine hydrochloride, 3 mg Phosphate buffer and… |
| Registration date | Jun 29, 2021 |
| Target size | 30 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: